Clinical trial
4DXV for Targeting in Bronchoscopic Lung Volume Reduction
NCT04786171 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 4DXV for Targeting in Bronchoscopic Lung Volume Reduction
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 7, 2021
- Completion date
- May 30, 2024
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd, emphysema, hyperinflation